Journal article
TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization
R Lim, G Barker, M Lappas
Reproductive Sciences | Published : 2014
Abstract
Preeclampsia, a major cause of maternal and perinatal morbidity and mortality, is thought to be attributable to dysregulation of trophoblast invasion and differentiation. Microarray studies have shown that triggering receptor expressed on myeloid cells (TREM) 1, a cell surface molecule involved in the inflammatory response, is increased in preeclamptic placentas. The aim of this study was to determine the level of TREM-1 expression in severe early-onset preeclamptic placentas and its functional role in trophoblast differentiation. Placenta was obtained from women with severe early-onset preeclampsia (n = 19) and gestationally matched preterm controls placentas (n = 8). The TREM-1 expression ..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Martha Lappas was a recipient of a National Health and Medical Research Council (NHMRC) Career Development Fellowship (grant no. 454777 and 1047025). Funding for ChemiDoc XRS and xMark microplate absorbance spectrophotometer was provided by the Medical Research Foundation for Women and Babies. The Mercy Research Foundation also provided some funding for this project.